Current Headlines

  1. Air Liquide Announces the Acquisition PDP Couriers
    2/9/2016

    CRYO International, an Air Liquide group subsidiary specializing in temperature-controlled1 logistics solutions, has just acquired PDP Couriers, a major player in the customized transport of high value- added products for the pharmaceutical and biotechnology industries.

  2. Tobira Therapeutics Completes Patient Recruitment For ORION Phase 2a Study
    2/9/2016

    Tobira Therapeutics, Inc. (NASDAQ: TBRA), a biopharmaceutical company developing novel treatments for non-alcoholic steatohepatitis (NASH) and other serious immuno-inflammatory and fibrotic diseases, announced that it has completed recruitment for the Phase 2a ORION study.

  3. PDS Biotechnology Signs Agreement With National Cancer Institute
    2/9/2016

    PDS Biotechnology (PDS), a clinical-stage biopharmaceutical company focused on developing a pipeline of simpler, safer and more effective cancer immunotherapies based on its novel Versamune® platform, today announced that the Company has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), an Institute of the U.S. National Institutes of Health. 

  4. Sartorius Stedim Offers New Crossflow Filtration System For Process Development
    2/8/2016

    Sartorius Stedim Biotech (SSB), an international leading supplier for the biopharmaceutical industry, announces the launch of SARTOFLOW Smart, the smart and easy benchtop crossflow system for optimized ultra- and diafiltration applications.

  5. Sangamo Announces FDA Clearance Of Investigational New Drug Application
    2/8/2016

    Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for SB-318, a single treatment strategy intended to provide a life-long therapy for Mucopolysaccharidosis Type I (MPS I).

  6. Marken The Preferred Partner To Fight Zika Virus
    2/8/2016

    Marken announced recently they are working with key pharma partners in the race to find a vaccine and treatment for the Zika virus, declared as a public health emergency by the World Health Organization (WHO) earlier this week.

  7. Ratan Tata Invests In Invictus Oncology
    2/8/2016

    Invictus Oncology Private Limited, an innovation-driven oncology company developing next generation cancer therapeutics that are more effective and less toxic, today announced that chairman emeritus of Tata Sons Limited, Mr Ratan N. Tata, has invested in the company as part of the first close of Invictus's Series A financing round, joining existing investors Navam Capital and Aarin Capital.

  8. HemaFlo Announces Issuance of Key Patent for NephroFlow
    2/8/2016

    HemaFlo Therapeutics, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued US Patent Number 9,119,880 covering the use of NephroFlow to treat acute kidney injury (AKI).

  9. Ametek Announces Two Acquisitions
    2/5/2016

    Brookfield Engineering Broadens AMETEK’s Laboratory Instrumentation Platform ESP/SurgeX Expands AMETEK’s Power Protection Platform

  10. ATCC Supporting Zika Virus Research
    2/5/2016

    ATCC, the premier global biological materials resource and standards organization, is poised to assist the medical and life science researchers that are working to address the evolving concerns around Zika Virus infection.